Research ArticlesThe Role of P-Glycoprotein and Canalicular Multispecific Organic Anion Transporter in the Hepatobiliary Excretion of Drugs
References and Notes (191)
Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells
Biochim. Biophys. Acta
(1973)- et al.
P-glycoprotein and multidrug resistance
Curr. Opin. Genet. Dev.
(1996) - et al.
Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport
Biochim. Biophys. Acta
(1995) - et al.
Biology of the multidrug resistance-associated protein
MRP. Eur. J. Cancer
(1996) - et al.
Multidrug resistance mediated by the multidrug resistance protein (MRP) gene
Biochem. Pharmacol.
(1996) - et al.
Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone
J. Biol. Chem.
(1992) - et al.
Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
Cell
(1994) Mutation of glycine 185 to valine alters the ATPase function of the human P-glycoprotein expressed in Sf9 cells
J. Biol. Chem.
(1995)- et al.
Amino acid substitutions in the first transmembrane domain (TM1) of P-glycoprotein that alter substrate specificity
FEBS Lett.
(1997) - et al.
Is the multidrug transporter a flippase?
Trends Biochem. Sci.
(1992)
Intestinalsecretion of drugs
The role of P-glycoprotein and related drug efflux sstems in limiting oral drug absorption. Adv. Drug Deliv. Rev.
(1997)
Functional expression of the multidrug resistance-associated protein in the yeast Saccharomyces cerevisiae
J. Biol. Chem.
(1996)
Mechanisms of multidrug resistance in HL60 cells
Analysis of resistance associated membrane proteins and levels of mdr gene expression. Biochem. Pharmacol.
(1989)
Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles
Demonstration of glutathione-dependent vincristine transport. J. Biol. Chem.
(1996)
The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates
J. Biol. Chem.
(1994)
Coordinated induction of MRP/ GS-X pump and gamma-glutamylcysteine synthetase by heavy metals in human leukemia cells
J. Biol. Chem.
(1996)
Transport of the glutathione conjugate of ethacrynic acid by the human multidrug resistance protein MRP
FEBSLett.
(1996)
ATP-dependent 17 beta-estradiol 17-(beta-D-glucuronide) transport by multidrug resistance protein (MRP)
Inhibition by cholestatic steroids. J. Biol. Chem.
(1996)
The yeast cadmium factor protein (YCF1) is a vacuolar glutathione S-conjugate pump
J. Biol. Chem.
(1996)
Glutathione-associated cis-diamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance
J. Biol. Chem.
(1993)
GS-X pump is functionally overexpressed in cis-diamminedichloroplatinum(II)-resistant human leukemia HL-60 cells and down-regulated by cell differentiation
J. Biol. Chem.
(1994)
The ATP-dependent glutathione S-conjugate export pump
Trends Biochem. Sci.
(1992)
Hepatobiliary elimination of cationic drugs: the role of P-glycoproteins and other ATP-dependent transporters
Adv. Drug Deliv. Rev.
(1997)
The function of Gp170, the multidrug resistance gene product, in rat liver canalicular membrane vesicles
J. Biol. Chem.
(1989)
Kinetic analysis of hepatobiliary transport of vincristine in perfused rat liver. Possible roles of P-glycoprotein in biliary excretion of vincristine
J. Hepatol.
(1992)
Induction of hepatic P-glycoprotein enhances biliary excretion of vincristine in rats
J. Hepatol.
(1995)
ATP-dependent export pumps and their inhibition by cyclosporins
Adv. Enzyme Regul.
(1994)
Modulation by verapamil of vincristine pharmacokinetics and toxicity in mice bearing human tumor xenografts
Biochem. Pharmacol.
(1989)
L.; Gosland, M. P. MDR expression in normal tissues. Pharmacologic implications for the clinical use of P-glycoprotein inhibitors. Hematol. Oncol. Clin
North America
(1995)
Multidrug resistance gene family and chemical carcinogens
Pharmacol. Ther.
(1991)
Effect of colchicine and heat shock on multidrug resistance gene and P-glycoprotein expression in rat liver
J. Hepatol.
(1994)
Mechanisms of resistance to daunorubicin in Ehrlich ascites tumor cells
Cancer Res.
(1978)
ABC transporters: From microorganisms to man
Annu. Rev. Cell Biol.
(1992)
P-glycoproteins and multidrug resistance
Annu. Rev. Pharmacol. Toxicol.
(1996)
Biochemistry of multidrug resistance mediated by the multidrug transporter
Annu. Rev. Biochem.
(1993)
Genetic analysis of the multidrug transporter
Annu. Rev. Genet.
(1995)
In Principles of Antineoplasmic drug development and pharmacology
P-Glycoprotein mediates the efflux of quinidine across the blood-brain barrier
J. Pharmacol. Exp. Ther.
(1997)
Altered pharmacokinetics of vinblastine in Mdr1a P-glycoprotein-deficient Mice
J. Natl. Cancer Inst.
(1996)
Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A
J. Clin. Invest.
(1995)
P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs
J. Clin. Invest.
(1996)
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
Proc. Natl. Acad. Sci. U.S.A.
(1997)
Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr1a P-glycoprotein
Br. J. Pharmacol.
(1996)
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
Proc. Natl. Acad. Sci. U.S.A.
(1997)
Mutations to amino acids located in predicted transmembrane segment 6 (TM6) modulate the activity and substrate specificity of human P-glycoprotein
Biochemistry
(1994)
Molecular basis of preferential resistance to colchicine in multidrug-resistant human cells conferred by Gly-185- - - -Val-185 substitution in P-glycoprotein
Proc. Natl. Acad. Sci. U.S.A.
(1990)
Involvement of MDR1 P-glycoprotein in multifactorial resistance to methotrexate
Int. Natl. Cancer.
(1996)
P-glycoprotein confers methotrexate resistance in 3 T6 cells with deficient carrier-mediated methotrexate uptake
Proc. Natl. Acad. Sci. U.S.A.
(1996)
ATP-dependent transport of beta-estradiol 17-(beta-D-glucuronide) in rat canalicular membrane vesicles
Am. J. Physiol.
(1996)
Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues
Proc. Natl. Acad. Sci. U.S.A.
(1987)
Cited by (123)
Pharmacogenomics and personalized medicine in the treatment of human diseases
2018, Molecular Pathology: The Molecular Basis of Human DiseaseStudies on pharmacokinetic mechanism of phenytoin resistance in refractory epilepsy
2013, Journal of Pharmaceutical SciencesPharmacogenomics and Personalized Medicine in the Treatment of Human Diseases
2009, Molecular Pathology: The Molecular Basis of Human DiseaseDrug Excretion
2009, PharmacologyDrug Excretion
2009, Pharmacology: Principles and Practice
Copyright © 1998 Wiley‐Liss, Inc. and the American Pharmaceutical Association. Published by Elsevier Inc. All rights reserved.